Log in or Sign up for Free to view tailored content for your specialty!
Pharmacology News
Many women with migraine avoid pregnancy
Nearly 20% of women with migraine reported avoiding pregnancy because of the condition, according to research published in Mayo Clinic Proceedings.
FDA approved opioids based on limited data, sometimes ‘flawed’ trial designs
The FDA has often approved new drug applications for opioids based on trials of inadequate length that included only patients who could tolerate the drugs, according to researchers.
Log in or Sign up for Free to view tailored content for your specialty!
Phase 3 study evaluates tolperisone for back spasm pain
A phase 3, double-blind, randomized, placebo-controlled study is evaluating tolperisone in patients experiencing pain from acute muscle spasms in their back, according to a poster presentation at this year’s virtual PAINWeek meeting.
Multivitamin, mineral supplement may lower illness severity
Multivitamin and mineral supplementation may decrease the length and severity of illnesses such as respiratory infections in older adults, according to research published in Nutrients.
FDA requires benzodiazepine labels to include addiction risks
The FDA announced that manufacturers of benzodiazepines will be required to update their boxed warning to list the risks for abuse, addiction, misuse, physical dependence and withdrawal reactions associated with the drugs.
Some dietary supplements for cognitive enhancement contain unapproved drugs
Over-the-counter dietary supplements that claim to improve mental focus and memory contain unapproved drugs, according to research published in Neurology, the medical journal of the American Academy of Neurology.
VA, DOD dyslipidemia guideline focuses on doses, tests, prevention, healthy lifestyle
A dyslipidemia guideline from the Department of Veterans Affairs and Department of Defense provided recommendations on statin dosing, tests for predicting CVD risk, primary and secondary CVD prevention, nutrition and exercise.
Buprenorphine buccal film effective for moderate, severe chronic low back pain
Buprenorphine buccal film treatment led to greater reductions in pain than placebo among patients with moderate or severe chronic low back pain with and without previous opioid exposure, according to research presented at this year’s virtual PAINWeek meeting.
Intranasal DHE delivery system safe, effective against migraine in phase 3 trial
Biotech company Impel Neuropharma announced that its precision olfactory delivery device, or POD, safely delivered the company’s nasal dihydroergotamine-based INP104 treatment to patients with migraine.
Belimumab plus standard therapy superior to standard therapy alone for lupus nephritis
A 2-year randomized controlled trial has found that belimumab plus standard therapy is superior to standard therapy alone in patients with lupus nephritis, according to data published in the New England Journal of Medicine.
-
Headline News
A potential new paradigm for treating acute migraine: Timolol nasal spray
November 15, 20245 min read -
Headline News
AI-enabled video of skin on face, hands may detect high blood pressure, diabetes
November 15, 20242 min read -
Headline News
‘Troubling’ data show lack of awareness about lung cancer screening
November 15, 20242 min read
-
Headline News
A potential new paradigm for treating acute migraine: Timolol nasal spray
November 15, 20245 min read -
Headline News
AI-enabled video of skin on face, hands may detect high blood pressure, diabetes
November 15, 20242 min read -
Headline News
‘Troubling’ data show lack of awareness about lung cancer screening
November 15, 20242 min read